Cholangitis other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(11 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cholangitis}}
{{Cholangitis}}
{{CMG}}; {{AE}} {{FH}}
{{CMG}}; {{AE}}{{ADS}}


==Overview==
==Overview==
[[Blood tests]] to check levels of liver enzymes are the first step in diagnosing cholangitis. Doctors can confirm the diagnosis using [[cholangiography]], which provides pictures of the [[bile ducts]].
[[Endoscopic retrograde cholangiopancreatography]] ([[ERCP]]) is considered a gold standard test for diagnosing [[biliary obstruction]]. [[Magnetic resonance cholangiopancreatography]] (MRCP) and [[percutaneous transhepatic cholangiography]] ([[PTCA]]) are the most [[Sensitivity (tests)|sensitive]] techniques to correctly determine the underlying cause and level of [[biliary obstruction]] in patients with acute cholangitis when [[Endoscopic retrograde cholangiopancreatography|ERCP]] fails.  


==Other Diagnostic Studies==
==Other Diagnostic Findings==
===Blood Tests===
===Endoscopic retrograde cholangiopancreatography (ERCP)===
A routine blood test can show:<ref name="pmid17556149">{{cite journal |vauthors=Kinney TP |title=Management of ascending cholangitis |journal=Gastrointest. Endosc. Clin. N. Am. |volume=17 |issue=2 |pages=289–306, vi |year=2007 |pmid=17556149 |doi=10.1016/j.giec.2007.03.006 |url=}}</ref>
ERCP is the preferred imaging method for diagnosing [[biliary obstruction]] as it is both diagnostic and therapeutic. [[Endoscopic retrograde cholangiopancreatography|ERCP]] involves the use of [[endoscopy]] to pass a small [[cannula]] into the [[bile duct]]. [[Radiocontrast]] is then injected to opacify the duct, and [[x-rays]] are taken to get a visual impression of the [[biliary system]]. Findings on an [[Endoscopic retrograde cholangiopancreatography|ERCP]] suggestive of/diagnostic of acute cholangitis include:
*Features of acute inflammation (raised [[white blood cell]] count and elevated C-reactive protein levels)
*A protuberant ampulla from an impacted [[gallstone]] in the [[common bile duct]], or the frank extrusion of [[pus]] from the [[common bile duct]] orifice.<ref name="pmid17556149">{{cite journal |vauthors=Kinney TP |title=Management of ascending cholangitis |journal=Gastrointest. Endosc. Clin. N. Am. |volume=17 |issue=2 |pages=289–306, vi |year=2007 |pmid=17556149 |doi=10.1016/j.giec.2007.03.006 |url=}}</ref>
*Abnormal [[liver function tests]] (LFTs)
**LFTs will be consistent with the following obstructions:
***Raised [[bilirubin]]
***Increased alkaline phosphate levels
***Increased γ-glutamyl transpeptidase
**In early stages, pressure on the liver cells could be the main result on LFTs, so they might resemble those in [[hepatitis]], with elevations in [[alanine transaminase]] and [[aspartate transaminase]].


Blood cultures are often performed in people with [[fever]] and evidence of acute infection. These yield the bacteria causing the infection in 36% of cases, usually after 24–48 hours of incubation. [[Bile]], too, may be sent for culture during [[endoscopic retrograde cholangiopancreatography]] (ERCP). The most common types of bacteria linked to cholangitis are [[gram-positive]] and [[gram-negative]].<ref name="book123">{{Citation
=== Percutaneous transhepatic cholangiography (PTCA) ===
| last1  = Vaishnavi
In case the [[Endoscopic retrograde cholangiopancreatography|ERCP]] is unsuccessful, [[percutaneous transhepatic cholangiography]] (PTCA) can be used to allow access to the [[biliary tree]].<ref name="pmid13684978">{{cite journal |vauthors=ATKINSON M, HAPPEY MG, SMIDDY FG |title=Percutaneous transhepatic cholangiography |journal=Gut |volume=1 |issue= |pages=357–65 |year=1960 |pmid=13684978 |pmc=1413224 |doi= |url=}}</ref><ref name="urlPrimary Sclerosing Cholangitis">{{cite web |url=http://www.niddk.nih.gov/health-information/health-topics/liver-disease/primary-sclerosing-cholangitis/Pages/facts.aspx |title=Primary Sclerosing Cholangitis |format= |work= |accessdate=April 20 2016}}</ref>
| first1 = C
*The PTCA procedure involves inserting a needle through the skin and placing a thin tube into a [[duct]] in the [[liver]].
| lastauthoramp = yes
*Dye is injected through the tube and [[x-rays]] are then taken. 
| title    = Infections of the Gastrointestinal System
For diagnostic purposes, ERCP has now generally been replaced by MRCP. ERCP is only used first-line in critically ill patients in whom delay for diagnostic tests is not acceptable.
| publisher = Jaypee Brothers Medical Publishing
*If the index of suspicion for cholangitis is high, an [[Endoscopic retrograde cholangiopancreatography|ERCP]] is typically done to achieve drainage of the obstructed [[common bile duct]].<ref name="pmid17556149">{{cite journal |vauthors=Kinney TP |title=Management of ascending cholangitis |journal=Gastrointest. Endosc. Clin. N. Am. |volume=17 |issue=2 |pages=289–306, vi |year=2007 |pmid=17556149 |doi=10.1016/j.giec.2007.03.006 |url=}}</ref>
| place    = New Delhi, India
 
| edition = 1
===Magnetic resonance cholangiopancreatography (MRCP)===
| year    = 2013
*Useful in patients with postcholecystectomy and in patients with non-conclusive [[Endoscopic retrograde cholangiopancreatography|ERCP]].<ref name="pmid16691174">{{cite journal |vauthors=Gallix BP, Aufort S, Pierredon MA, Garibaldi F, Bruel JM |title=[Acute cholangitis: imaging diagnosis and management] |language=French |journal=J Radiol |volume=87 |issue=4 Pt 2 |pages=430–40 |year=2006 |pmid=16691174 |doi= |url=}}</ref>
}}</ref>  
**This safe and painless test is increasingly used for [[diagnosis]].
*Gram-negative includes:
*The only disadvantage is that smaller stones can be missed on a [[MRCP]].<ref name="pmid17556149">{{cite journal |vauthors=Kinney TP |title=Management of ascending cholangitis |journal=Gastrointest. Endosc. Clin. N. Am. |volume=17 |issue=2 |pages=289–306, vi |year=2007 |pmid=17556149 |doi=10.1016/j.giec.2007.03.006 |url=}}</ref>
**[[Escherichia coli]] (25–50%)
**[[Klebsiella]] (15–20%)
**[[Enterobacter]] (5–10%)
*Of the gram-positive strains, 10–20% of cases are caused by [[Enterococcus]].


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs overview]]
{{WikiDoc Help Menu}}
[[Category:Disease]]
{{WikiDoc Sources}}
 
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
 
[[Category:FinalQCRequired]]
{{WikiDoc Help Menu}}
[[Category:Disease]]
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Surgery]]

Latest revision as of 20:55, 29 July 2020

Cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangitis other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangitis other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangitis other diagnostic studies

CDC on Cholangitis other diagnostic studies

Cholangitis other diagnostic studies in the news

Blogs on Cholangitis other diagnostic studies

Directions to Hospitals Treating Cholangitis

Risk calculators and risk factors for Cholangitis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Endoscopic retrograde cholangiopancreatography (ERCP) is considered a gold standard test for diagnosing biliary obstruction. Magnetic resonance cholangiopancreatography (MRCP) and percutaneous transhepatic cholangiography (PTCA) are the most sensitive techniques to correctly determine the underlying cause and level of biliary obstruction in patients with acute cholangitis when ERCP fails.

Other Diagnostic Findings

Endoscopic retrograde cholangiopancreatography (ERCP)

ERCP is the preferred imaging method for diagnosing biliary obstruction as it is both diagnostic and therapeutic. ERCP involves the use of endoscopy to pass a small cannula into the bile duct. Radiocontrast is then injected to opacify the duct, and x-rays are taken to get a visual impression of the biliary system. Findings on an ERCP suggestive of/diagnostic of acute cholangitis include:

Percutaneous transhepatic cholangiography (PTCA)

In case the ERCP is unsuccessful, percutaneous transhepatic cholangiography (PTCA) can be used to allow access to the biliary tree.[2][3]

  • The PTCA procedure involves inserting a needle through the skin and placing a thin tube into a duct in the liver.
  • Dye is injected through the tube and x-rays are then taken.

For diagnostic purposes, ERCP has now generally been replaced by MRCP. ERCP is only used first-line in critically ill patients in whom delay for diagnostic tests is not acceptable.

  • If the index of suspicion for cholangitis is high, an ERCP is typically done to achieve drainage of the obstructed common bile duct.[1]

Magnetic resonance cholangiopancreatography (MRCP)

  • Useful in patients with postcholecystectomy and in patients with non-conclusive ERCP.[4]
    • This safe and painless test is increasingly used for diagnosis.
  • The only disadvantage is that smaller stones can be missed on a MRCP.[1]

References

  1. 1.0 1.1 1.2 Kinney TP (2007). "Management of ascending cholangitis". Gastrointest. Endosc. Clin. N. Am. 17 (2): 289–306, vi. doi:10.1016/j.giec.2007.03.006. PMID 17556149.
  2. ATKINSON M, HAPPEY MG, SMIDDY FG (1960). "Percutaneous transhepatic cholangiography". Gut. 1: 357–65. PMC 1413224. PMID 13684978.
  3. "Primary Sclerosing Cholangitis". Retrieved April 20 2016. Check date values in: |accessdate= (help)
  4. Gallix BP, Aufort S, Pierredon MA, Garibaldi F, Bruel JM (2006). "[Acute cholangitis: imaging diagnosis and management]". J Radiol (in French). 87 (4 Pt 2): 430–40. PMID 16691174.


Template:WikiDoc Sources